Genetic Technologies Limited
GNTLF
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.39M | -7.15M | -7.88M | -8.14M | -8.44M |
| Total Depreciation and Amortization | 209.80K | 239.30K | 268.50K | 300.40K | 335.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.22M | 1.66M | 1.08M | 2.19M | 3.33M |
| Change in Net Operating Assets | 181.40K | 181.40K | 181.40K | -42.30K | -268.90K |
| Cash from Operations | -3.78M | -5.06M | -6.35M | -5.68M | -5.05M |
| Capital Expenditure | -7.90K | -14.80K | -21.60K | -24.80K | -28.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 301.40K | 200.90K | 96.70K | 124.30K | 152.90K |
| Cash from Investing | 293.60K | 186.20K | 75.20K | 99.60K | 124.80K |
| Total Debt Issued | 601.00K | 601.00K | 601.00K | 300.50K | -- |
| Total Debt Repaid | -480.40K | -414.60K | -348.80K | -345.80K | -342.80K |
| Issuance of Common Stock | 2.61M | 2.60M | 2.58M | 4.87M | 7.17M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -90.60K | -48.70K | -6.80K | -462.50K | -918.20K |
| Cash from Financing | 1.74M | 1.80M | 1.86M | 2.90M | 4.00M |
| Foreign Exchange rate Adjustments | -43.90K | -51.10K | -58.30K | 33.90K | 127.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.79M | -3.13M | -4.48M | -2.65M | -796.70K |